These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14504423)

  • 1. Current attitudes to the therapy of vasculitis.
    Jayne D
    Kidney Blood Press Res; 2003; 26(4):231-9. PubMed ID: 14504423
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppressive treatment for vasculitis associated with Lyme borreliosis.
    Komdeur R; Zijlstra JG; van der Werf TS; Ligtenberg JJ; Tulleken JE
    Ann Rheum Dis; 2001 Jul; 60(7):721. PubMed ID: 11436861
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulse versus daily oral cyclophosphamide in ANCA-associated vasculitis.
    Levine SM
    Ann Intern Med; 2010 Jan; 152(1):65; author reply 65. PubMed ID: 20048281
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
    Tervaert JW; Stegeman CA
    Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.
    Lapraik C; Watts R; Bacon P; Carruthers D; Chakravarty K; D'Cruz D; Guillevin L; Harper L; Jayne D; Luqmani R; Mooney J; Scott D;
    Rheumatology (Oxford); 2007 Oct; 46(10):1615-6. PubMed ID: 17804455
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Jayne D; Rasmussen N; Andrassy K; Bacon P; Tervaert JW; Dadoniené J; Ekstrand A; Gaskin G; Gregorini G; de Groot K; Gross W; Hagen EC; Mirapeix E; Pettersson E; Siegert C; Sinico A; Tesar V; Westman K; Pusey C;
    N Engl J Med; 2003 Jul; 349(1):36-44. PubMed ID: 12840090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy in autoimmune disease: vasculitis.
    Carruthers D; Bacon P
    Springer Semin Immunopathol; 2001; 23(1-2):91-108. PubMed ID: 11455864
    [No Abstract]   [Full Text] [Related]  

  • 8. Vasculitis: clinical approach, pathophysiology and treatment.
    Kallenberg CG
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):656-9. PubMed ID: 11020951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANCA-associated vasculitis: diagnosis and treatment in the elderly.
    Parry R; Sherwin S; Fletcher V; Medcalf P
    Postgrad Med J; 1996 Jul; 72(849):423-6. PubMed ID: 8935603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vasculitis and diabetes insipidus, reversible by administration of cyclophosphamide].
    Mallet H; Dupond JL
    Presse Med; 1995 Nov; 24(36):1709. PubMed ID: 8545406
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation of chronic hepatitis C virus infection by cyclophosphamide in a patient with cANCA-positive vasculitis.
    Arend SM; Hagen EC; Kroes AC; Bruijn JA; van der Woude FJ
    Nephrol Dial Transplant; 1995; 10(6):884-7. PubMed ID: 7566624
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug therapy of vasculitis with immunosuppressive agents, immunomodulators and cyclosporin A].
    Abe C
    Nihon Rinsho; 1985 Oct; 43(10):2196-9. PubMed ID: 3912547
    [No Abstract]   [Full Text] [Related]  

  • 13. L44. Management of relapses in vasculitis.
    Mouthon L
    Presse Med; 2013 Apr; 42(4 Pt 2):619-22. PubMed ID: 23477710
    [No Abstract]   [Full Text] [Related]  

  • 14. [The therapy of vasculitis].
    Andrassy K; Waldherr R; Hergesell O; Ritz E
    Dtsch Med Wochenschr; 1996 Aug; 121(31-32):985-7. PubMed ID: 8765402
    [No Abstract]   [Full Text] [Related]  

  • 15. [New strategies in diagnosis and therapy of vasculitides].
    Stierle HE
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():143-6. PubMed ID: 16802540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necrotizing vasculitis--a 2009 update.
    Sharaf PH; Yazici Y
    Bull NYU Hosp Jt Dis; 2009; 67(3):303-5. PubMed ID: 19852754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of ANCA-associated vasculitis.
    Langford CA
    N Engl J Med; 2003 Jul; 349(1):3-4. PubMed ID: 12840085
    [No Abstract]   [Full Text] [Related]  

  • 18. Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Sanders JS; Slot MC; Stegeman CA
    N Engl J Med; 2003 Nov; 349(21):2072-3; author reply 2072-3. PubMed ID: 14627795
    [No Abstract]   [Full Text] [Related]  

  • 19. L52. Vasculitis treatment: is it time to change the standard of care for ANCA-associated vasculitis?
    Hoffman GS
    Presse Med; 2013 Apr; 42(4 Pt 2):643-50. PubMed ID: 23474045
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
    De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR
    Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.